Quantcast

Latest Retinitis pigmentosa Stories

2010-06-14 13:01:08

Researchers working toward cure for pigmentosa; other retinal diseases Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease. The study appears in the Journal of the Federation of American Societies for Experimental Biology (FASEB). The research, led by Muna Naash, Ph.D., at the...

2010-06-03 04:20:00

TOKYO, June 3 /PRNewswire/ -- We are pleased to announce that the Phase II clinical study of UF-021, product name Ocuseva (TM), which we are developing as a therapeutic drug for retinitis pigmentosa (note 1), has been completed. Retinitis pigmentosa is an intractable disease where therapeutic drugs or therapeutic methods have not been established yet. When the disease of retinitis pigmentosa progresses, the visual field narrows irreversibly and furthermore, in the late stage, they may...

f63af4b5b2056807393b1146936ea0411
2010-05-27 07:57:10

Complex tissue structure "“ a first "“ offers hope to millions with degenerative eye disorders UC Irvine scientists have created an eight-layer, early stage retina from human embryonic stem cells, the first three-dimensional tissue structure to be made from stem cells. It also marks the first step toward the development of transplant-ready retinas to treat eye disorders such as retinitis pigmentosa and macular degeneration that affect millions. "We made a complex structure...

2010-05-03 14:52:00

Honored for innovations that improve vision for visually impaired BOSTON, May 3 /PRNewswire-USNewswire/ -- Dr. Eli Peli, a senior scientist at Schepens Eye Research Institute, has been selected by the Society for Information Display for the Otto Schade Prize. Peli will receive the award at a special presentation at the Society's Awards Banquet on May 24, 2010 in Seattle. Peli was chosen "for his many outstanding contributions to vision science and its application to image quality...

15a4a91e4d70473612e4fbc5b0312cd21
2010-04-29 10:42:56

Veterinary vision scientists at the University of Pennsylvania have safely and successfully used a viral vector in targeting a class of photoreceptors of the retina called rods, a critical first step in developing gene therapies for inherited blindness caused by rod degeneration. In this study, the viral vector, or missile that carries the genetic material designed to correct a DNA mutation, was not intended to treat a disease but to demonstrate through the use of a fluorescent protein that a...

2010-04-21 14:47:00

PHILADELPHIA -- Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness. Achromatopsia is a rare autosomal recessive disorder with an estimated prevalence in human beings of about 1 in 30,000 to 50,000. It primarily affects the function of the cone photoreceptors in the retina and serves as a...

2010-04-06 09:24:00

BONN, Germany, April 6 /PRNewswire/ -- IMI Intelligent Medical Implants, a pioneer developer of a system designed to restore vision to people blinded by diseases such as retinitis pigmentosa or macular degeneration, has named veteran life sciences executive, Robert J. Rosenthal, Ph.D., chief executive officer. He is also a member of the IMI board of directors. Dr. Rosenthal has more than 20 years of experience fostering product innovation and building value for customers, shareholders, and...

2010-03-31 16:38:44

New research in the FASEB Journal shows that nucleic acid nanoparticle platform delivery technology achieves successful gene transfer and reverses affects of retinitis pigmentosa in mice Take a look at this: Scientists from Buffalo, Cleveland, and Oklahoma City made a huge step toward making the blind see, and they did it by using a form of gene therapy that does not involve the use of modified viruses. In a research report published in the April 2010 print issue of The FASEB Journal...

9a05553aa5f726236396c9e6ef6fb9ca1
2010-03-22 13:59:01

Tel Aviv University pioneers research for new retinal implant technology Television's Six Million Dollar Man foresaw a future when man and machine would become one. New research at Tel Aviv University is making this futuristic "vision" of bionics a reality. Prof. Yael Hanein of Tel Aviv University's School of Electrical Engineering has foundational research that may give sight to blind eyes, merging retinal nerves with electrodes to stimulate cell growth. Successful so far in animal models,...

2010-03-02 07:30:00

NEW YORK, March 2 /PRNewswire-USNewswire/ -- Lighthouse International, the non-profit leader in vision healthcare, research, education and advocacy, launches a new website that features the first customizable, low-vision simulator that shows how a person with an eye disease sees the world. Visitors can choose a video from YouTube and select a filter that simulates retinitis pigmentosa, macular degeneration, glaucoma or diabetic retinopathy. Link to VISION SIMULATOR According to...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related